Snowball logo
logo
3088

MatsukiyoCocokara & Co

3088 TSE
¥2,704.00+¥17.50  (0.65%)
Start your journey to financial independence
Snowball will help you to track your portfolio, plan deposits to your brokerage account and increase passive income
Start

Frequently Asked Questions

What sector does MatsukiyoCocokara & Co (3088) operate in?

MatsukiyoCocokara & Co belongs to the Healthcare sector and operates in the Pharmaceutical Retailers industry.

What is MatsukiyoCocokara & Co (3088) current stock price?

As of the latest data, MatsukiyoCocokara & Co stock price is ¥2,704, with a previous close of ¥2,687. MatsukiyoCocokara & Co gained ¥18 in the last trading session, representing a 0.65% increase.

What is MatsukiyoCocokara & Co (3088) current market capitalization?

MatsukiyoCocokara & Co market cap is approximately 1.09 trillion.

What is MatsukiyoCocokara & Co (3088) Earnings Per Share (EPS)?

The trailing EPS is ¥125.

What is MatsukiyoCocokara & Co (3088) Price-to-Earnings (P/E) ratio?

MatsukiyoCocokara & Co current P/E ratio is 21.71.

What is MatsukiyoCocokara & Co (3088) EBITDA?

MatsukiyoCocokara & Co EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 29.58 billion.

Does MatsukiyoCocokara & Co (3088) dividends?

Yes. MatsukiyoCocokara & Co pays semiannual dividends with a forward yield of 1.55% and a forward payout of ¥42 per share.

When is the next ex-dividend date for MatsukiyoCocokara & Co (3088)?

The next ex-dividend date is scheduled for September 28, 2025.

How did MatsukiyoCocokara & Co (3088) perform in its most recent earnings report?

In the last report (December 31, 2024), MatsukiyoCocokara & Co posted an EPS surprise of 10.5% and a revenue surprise of 1.33%.

When is MatsukiyoCocokara & Co (3088) next earnings report?

MatsukiyoCocokara & Co is expected to release its next earnings report on March 31, 2025.

What is MatsukiyoCocokara & Co (3088) beta (volatility) score?

MatsukiyoCocokara & Co has a beta of -0.016, indicating lower volatility than the overall market.